Felicitas Rataj

1.2k total citations
19 papers, 661 citations indexed

About

Felicitas Rataj is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Felicitas Rataj has authored 19 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Felicitas Rataj's work include CAR-T cell therapy research (10 papers), Immunotherapy and Immune Responses (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Felicitas Rataj is often cited by papers focused on CAR-T cell therapy research (10 papers), Immunotherapy and Immune Responses (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Felicitas Rataj collaborates with scholars based in Germany, France and Switzerland. Felicitas Rataj's co-authors include Sebastian Kobold, Stefan Endres, Stanislav Pantelyushin, Johannes vom Berg, Constanze Heise, Klaus‐Peter Janssen, Günter Vollmer, Oliver Zierau, Binje Vick and Irmela Jeremias and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Oncogene.

In The Last Decade

Felicitas Rataj

19 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Felicitas Rataj Germany	14	471	310	222	102	98	19	661
Tracy E. Garrett United States	8	275 0.6×	109 0.4×	212 1.0×	58 0.6×	92 0.9×	10	403
LG Durrant United Kingdom	14	161 0.3×	217 0.7×	231 1.0×	31 0.3×	19 0.2×	26	497
Sarah B. Gitto United States	13	284 0.6×	224 0.7×	135 0.6×	26 0.3×	16 0.2×	28	433
Eric J. Hsu United States	11	239 0.5×	231 0.7×	173 0.8×	25 0.2×	39 0.4×	18	460
Mariano F. Zacarías Fluck Spain	8	236 0.5×	186 0.6×	176 0.8×	23 0.2×	24 0.2×	15	463
Ruizhan Tong China	11	203 0.4×	91 0.3×	211 1.0×	40 0.4×	17 0.2×	20	450
Harshita B. Gupta United States	11	470 1.0×	379 1.2×	231 1.0×	23 0.2×	26 0.3×	28	726
Alessia Ricupito Italy	6	216 0.5×	300 1.0×	284 1.3×	17 0.2×	73 0.7×	7	599

Countries citing papers authored by Felicitas Rataj

Since Specialization

Citations

This map shows the geographic impact of Felicitas Rataj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felicitas Rataj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felicitas Rataj more than expected).

Fields of papers citing papers by Felicitas Rataj

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Felicitas Rataj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felicitas Rataj. The network helps show where Felicitas Rataj may publish in the future.

Co-authorship network of co-authors of Felicitas Rataj

This figure shows the co-authorship network connecting the top 25 collaborators of Felicitas Rataj. A scholar is included among the top collaborators of Felicitas Rataj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felicitas Rataj. Felicitas Rataj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Lesch, Stefanie, et al.. (2022). PD-1-CD28 fusion protein strengthens mesothelin-specific TRuC T cells in preclinical solid tumor models. Cellular Oncology. 46(1). 227–235. 15 indexed citations

Krüger, Stephan, Volker Heinemann, Deepak Bararia, et al.. (2021). Alterations in regulatory T cells and immune checkpoint molecules in pancreatic cancer patients receiving FOLFIRINOX or gemcitabine plus nab-paclitaxel. Clinical & Translational Oncology. 23(11). 2394–2401. 13 indexed citations

Stenger, Dana, Theresa Kaeuferle, Semjon Willier, et al.. (2020). Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR. Blood. 136(12). 1407–1418. 123 indexed citations

Rataj, Felicitas, Josiane Denis, Odile Filhol, et al.. (2019). Targeting AU-rich element-mediated mRNA decay with a truncated active form of the zinc-finger protein TIS11b/BRF1 impairs major hallmarks of mammary tumorigenesis. Oncogene. 38(26). 5174–5190. 10 indexed citations

Rataj, Felicitas, Stefan Stoiber, Justyna Ogonek, et al.. (2018). High-affinity CD16-polymorphism and Fc-engineered antibodies enable activity of CD16-chimeric antigen receptor-modified T cells for cancer therapy. British Journal of Cancer. 120(1). 79–87. 44 indexed citations

Krupka, Christina, Katrin Deiser, Bettina Brauchle, et al.. (2018). Bifunctional PD-1 × αCD3 × αCD33 fusion protein reverses adaptive immune escape in acute myeloid leukemia. Blood. 132(23). 2484–2494. 78 indexed citations

Kobold, Sebastian, Stanislav Pantelyushin, Felicitas Rataj, & Johannes vom Berg. (2018). Rationale for Combining Bispecific T Cell Activating Antibodies With Checkpoint Blockade for Cancer Therapy. Frontiers in Oncology. 8. 285–285. 79 indexed citations

Rataj, Felicitas, Fabian Kraus, Michael Chaloupka, et al.. (2018). PD1-CD28 Fusion Protein Enables CD4+ T Cell Help for Adoptive T Cell Therapy in Models of Pancreatic Cancer and Non-hodgkin Lymphoma. Frontiers in Immunology. 9. 1955–1955. 22 indexed citations

Rataj, Felicitas, Felix Kraus, Simon Grassmann, et al.. (2018). Preclinical characterization of a PD-1-CD28 fusion receptor in CD4+ T cells for T cell-based immunotherapy of pancreatic cancer and Non-Hodgkin Lymphoma. European Journal of Cancer. 92. S4–S4. 1 indexed citations

10.

Wennhold, Kerstin, Martin Thelen, Hans Schlößer, et al.. (2017). Using Antigen-Specific B Cells to Combine Antibody and T Cell–Based Cancer Immunotherapy. Cancer Immunology Research. 5(9). 730–743. 28 indexed citations

11.

Cadilha, Bruno L., Klara Dorman, Felicitas Rataj, Stefan Endres, & Sebastian Kobold. (2017). Enabling T Cell Recruitment to Tumours as a Strategy for Improving Adoptive T Cell Therapy. European Oncology & Haematology. 13(1). 66–66. 9 indexed citations

12.

Voigt, Cornelia, Adrian Gottschlich, Anamarija Markota, et al.. (2017). Cancer cells induce interleukin-22 production from memory CD4⁺T cells via interleukin-1 to promote tumor growth. Proceedings of the National Academy of Sciences. 114(49). 12994–12999. 105 indexed citations

13.

Rataj, Felicitas, Agnès Desroches‐Castan, Juliette Le Douce, et al.. (2016). The cAMP pathway regulates mRNA decay through phosphorylation of the RNA-binding protein TIS11b/BRF1. Molecular Biology of the Cell. 27(24). 3841–3854. 17 indexed citations

14.

Rapp, Moritz, Simon Grassmann, Patrick Layritz, et al.. (2015). C-C chemokine receptor type-4 transduction of T cells enhances interaction with dendritic cells, tumor infiltration and therapeutic efficacy of adoptive T cell transfer. OncoImmunology. 5(3). e1105428–e1105428. 56 indexed citations

15.

Rataj, Felicitas, Frank Möller, Pia Hönscheid, et al.. (2014). Progesterone, as well as 17β-estradiol, is important for regulating AHR battery homoeostasis in the rat uterus. Archives of Toxicology. 89(3). 393–404. 16 indexed citations

16.

Rataj, Felicitas, Frank Möller, Oliver Zierau, et al.. (2012). Regulation of uterine AHR battery gene expression by 17β-Estradiol is predominantly mediated by estrogen receptor α. Archives of Toxicology. 86(10). 1603–1612. 21 indexed citations

17.

Rataj, Felicitas, Oliver Zierau, Patricia Anielski, et al.. (2012). Characterization of identity, metabolism and androgenic activity of 17-hydroxyandrosta-3,5-diene by GC–MS and a yeast transactivation system. Archives of Toxicology. 86(12). 1873–1884. 5 indexed citations

18.

Diel, Patrick, et al.. (2010). Long-term detection of methyltestosterone (ab-) use by a yeast transactivation system. Archives of Toxicology. 85(4). 285–292. 14 indexed citations

19.

Rataj, Felicitas, Oliver Zierau, Kai Ostermann, et al.. (2010). A novel combined approach to detect androgenic activities with yeast based assays in Schizosaccharomyces pombe and Saccharomyces cerevisiae. Toxicology Letters. 199(3). 410–415. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tracy E. Garrett Breakdown of academic impact, for papers by LG Durrant Breakdown of academic impact, for papers by Sarah B. Gitto Breakdown of academic impact, for papers by Eric J. Hsu Breakdown of academic impact, for papers by Mariano F. Zacarías Fluck Breakdown of academic impact, for papers by Ruizhan Tong Breakdown of academic impact, for papers by Harshita B. Gupta Breakdown of academic impact, for papers by Alessia Ricupito